Prestige Wealth Management Group’s iShares US Medical Devices ETF IHI Stock Holding History

Prestige Wealth Management Group’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.3K	Sell	471 -160	-25%	-$8.12K	﹤0.01%	335
2026 Q1	$33.7K	Sell	631 -59,174	-99%	-$3.47M	0.01%	290
2025 Q4	$3.72M	Buy	59,805 +151	+0.3%	+$9.32K	0.71%	30
2025 Q3	$3.58M	Sell	59,654 -1,143	-2%	-$69.9K	0.69%	29
2025 Q2	$3.81M	Buy	60,797 +1,690	+3%	+$102K	0.78%	27
2025 Q1	$3.56M	Buy	59,107 +8,726	+17%	+$542K	0.76%	27
2024 Q4	$2.94M	Buy	50,381 +360	+0.7%	+$21.4K	0.61%	33
2024 Q3	$2.96M	Sell	50,021 -731	-1%	-$41.7K	0.61%	31
2024 Q2	$2.84M	Sell	50,752 -1,833	-3%	-$103K	0.61%	37
2024 Q1	$3.08M	Buy	52,585 +577	+1%	+$32.6K	0.66%	32
2023 Q4	$2.81M	Buy	52,008 +460	+0.9%	+$22.5K	0.64%	33
2023 Q3	$2.51M	Sell	51,548 -1,078	-2%	-$57.3K	0.62%	33
2023 Q2	$2.97M	Sell	52,626 -393	-0.7%	-$21.6K	0.7%	27
2023 Q1	$2.86M	Sell	53,019 -847	-2%	-$45.1K	0.72%	25
2022 Q4	$2.83M	Sell	53,866 -455	-0.8%	-$23.1K	0.74%	25
2022 Q3	$2.56M	Buy	54,321 +716	+1%	+$37.2K	0.72%	27
2022 Q2	$2.7M	Buy	53,605 +2,504	+5%	+$136K	0.73%	25
2022 Q1	$3.12M	Sell	51,101 -6,009	-11%	-$358K	0.77%	24
2021 Q4	$3.76M	Sell	57,110 -2,845	-5%	-$182K	0.9%	21
2021 Q3	$3.76M	Buy	59,955 +11,583	+24%	+$739K	0.96%	21
2021 Q2	$2.91M	Sell	48,372 -348	-0.7%	-$20.1K	0.77%	25
2021 Q1	$2.68M	Buy	48,720 +2,856	+6%	+$158K	0.73%	25
2020 Q4	$2.5M	Buy	45,864 +14,244	+45%	+$745K	0.69%	27
2020 Q3	$1.58M	Buy	+31,620	New	+$1.53M	0.48%	31
2019 Q3	–	Sell	-2,892	Closed	-$116K	–	614
2019 Q2	$116K	Buy	+2,892	New	+$109K	0.07%	140

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Prestige Wealth Management Group's IHI Position: Q2 2026 in Review

Prestige Wealth Management Group reduced its iShares US Medical Devices ETF (IHI) stake by 25% in Q2 2026, selling an estimated $8.12K and leaving 471 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #335.

Prestige Wealth Management Group first reported a position in IHI in Q2 2019 and has held it in 25 quarters since. The position peaked at $3.81M in Q2 2025. 502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Prestige Wealth Management Group held 471 shares of iShares US Medical Devices ETF worth $23.3K as of Q2 2026.
Prestige Wealth Management Group sold 160 iShares US Medical Devices ETF shares in Q2 2026, an estimated $8.12K.
iShares US Medical Devices ETF made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #335 holding.
Prestige Wealth Management Group first reported a position in iShares US Medical Devices ETF in Q2 2019 and has held it in 25 quarters since.
Prestige Wealth Management Group's iShares US Medical Devices ETF position peaked at $3.81M in Q2 2025.
502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.